Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
0.8200
-0.0185 (-2.21%)
Nov 19, 2026, 4:00 PM EST - Market closed
LCTX's stock price has decreased by -53.67% in the past year and price targets may not have had time to catch up.
Lineage Cell Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $7 → $9 | Buy | Reiterates | $7 → $9 | +997.56% | Nov 13, 2026 |
| B. Riley Securities | B. Riley Securities | Buy Maintains $4 | Buy | Maintains | $4 | +387.80% | Sep 25, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $3 | Buy | Maintains | $3 | +265.85% | Aug 12, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $9 | Buy | Maintains | $9 | +997.56% | Aug 7, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jul 15, 2026 |